HOLLIS-EDEN PHARMACEUTICALS
Hollis-Eden Pharmaceuticals is focused on research and development of adrenal steroid hormones as pharmaceuticals for human health. Hollis-Eden Pharmaceuticals offers a hormonal signaling technology platform that develops small molecule compounds. The company offers TRIOLEX, a treatment for type 2 diabetes; and APOPTONE, a treatment for cancer. Hollis-Eden Pharmaceuticals was founded by Richard B. Hollis.
Similar Organizations
Berk Pharmaceutical
Berk Pharmaceutical is a Pharmaceuticals company.
Founder
More informations about "Hollis-Eden Pharmaceuticals"
Richard B. Hollis - Wikipedia
Richard B. Hollis is an American businessman. He is the founder, chairman, and CEO of Holonis, Inc., a San Diego–based software company. Hollis had previously founded Hollis-Eden Pharmaceuticals, a San Diego–based pharmaceutical company, in 1994. See details»
Hollis Eden Pharmaceuticals - Drug pipelines, Patents, Clinical trials ...
Explore Hollis Eden Pharmaceuticals with its drug pipeline, therapeutic area, technology platform, 1 news, and 8 literature, Drug:HE-2100, IDPS, HE-2200, Immunitin.See details»
Hollis-Eden Pharmaceuticals, Inc. - San Diego, USA - bionity.com
Aug 7, 2008 Hollis-Eden Pharmaceuticals, Inc. is a world leader in the development of a proprietary class of adrenal steroid hormones as novel pharmaceuticals for human health. …See details»
Hollis-Eden Pharmaceuticals 2002 Annual Report
IRH technology, Hollis-Eden is passionately driven with a consistency of purpose: to serve humanity by converting our technology into products strategicall positioned to play a major role …See details»
Press Release - SEC.gov
By focusing on these therapeutic areas with a restructured organization, we believe we can generate important clinical data that can enhance the value of our technology platform for our …See details»
Hollis-Eden Pharmaceuticals - Drug pipelines, Patents, Clinical …
Last update 02 May 2023. Hollis-Eden Pharmaceuticals. Private Company |See details»
Richard Hollis - Founder, Chairman & CEO at Holonis | The Org
Richard has over 25 years of experience in the pharmaceutical industry, having previously founded and served as chairman and CEO of Hollis-Eden Pharmaceuticals. Hollis-Eden was …See details»
Hollis-Eden Pharmaceuticals Company Profile | Management and …
Find contact information for Hollis-Eden Pharmaceuticals. Learn about their Manufacturing market share, competitors, and Hollis-Eden Pharmaceuticals's email format.See details»
Hollis-Eden Pharmaceuticals - Overview, News & Similar
Hollis-Eden Pharmaceuticals. Manufacturing · California, United States · 1,362 Employees. View Company Info for FreeSee details»
Hollis-Eden Pharmaceuticals Inc Announces Name Change to
Feb 18, 2010 BioSpace is the digital hub for life science news and jobs.We provide essential insights, opportunities and tools to connect innovative organizations and talented professionals …See details»
Press Release: Hollis-Eden Pharmaceuticals Announces …
Apr 27, 2007 Hollis-Eden Pharmaceuticals Announces Reorganization; to Cut Headcount by 25% SAN DIEGO -- Hollis-Eden Pharmaceuticals, Inc. today announced a restructuring …See details»
HE-2200 - Drug Targets, Indications, Patents - Synapse - Patsnap
Originator Organization. Virginia Commonwealth University. Active Organization-Inactive Organization. Virginia Commonwealth University Hollis Eden Pharmaceuticals. Drug Highest …See details»
Hollis-Eden Names James M. Frincke VP, R&D
Nov 24, 1997 He is also one of the industry's foremost experts in the development of leading-edge biotechnical discoveries into the clinical setting. This unique combination of background …See details»
Hollis Eden Pharmaceuticals | Working Group for New TB Drugs
Organization: Hollis Eden Pharmaceuticals. First Name: James. Last Name: Frincke. Country: United States. E-mail: [email protected]. Phone: 858-587-9333. Organization Type: …See details»
Richard B. Hollis - Founder, Chairman and CEO - Crunchbase
Primary Organization . Holonis . Location San Diego, California, United States; Regions Greater San Diego Area, West Coast, Western US; Gender ... Additionally, Richard B. Hollis has had 6 …See details»
Emerging Drug Developer: Hollis-Eden - Fierce Biotech
When Richard Hollis got up on March 7, he was the CEO of a company that was primarily known for its work advancing Neumune, a therapy for acute radiation syndrome and a prime …See details»
Hollis-Eden Pharmaceuticals Presents Positive Updated Data
Sep 25, 2008 Added Richard Hollis, Chairman and CEO of Hollis-Eden Pharmaceuticals, “Data presented today by Dr. Flores-Riveros at this World Congress on Insulin Resistance …See details»
Research programme: myelosuppression therapy - Hollis-Eden …
Oct 6, 2008 Hollis-Eden Pharmaceuticals was developing small molecule compounds with cellular and tissue regenerative properties for the treatment of chemotherapy-induced ... If …See details»
HE 3235 - AdisInsight - Springer
Harbor BioSciences (formerly Hollis-Eden Pharmaceuticals) was developing HE 3235, a small molecule oral therapy, for the treatment of cancer. As of September ... If your organization has …See details»